RCOR News and Press, Renovacor Inc Com From 09/20/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Tada Images / Shutterstock.com Rumble (NASDAQ: RUM ) stock is on the move Tuesday as the YouTube alternative is seeing volatility during its second day of trading. Rumble went public yesterday through ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock The Federal Reserve is planning additional interest rate hikes that investors will want to know about! The Fed rate hikes are expected tomorrow as the agency reveals the details of its latest ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock.com Renovacor (NYSEMKT: RCOR ) stock is gaining on Tuesday after announcing that Rocket Pharmaceuticals (NASDAQ: RCKT ) is acquiring it. That agreement will have Rocket Pharmaceutica...

Acquisition further strengthens Rocket’s leadership in AAV-based cardiac gene therapy and expands Company’s near-term clinical assets for the treatment of heart conditions Significant unmet medical need in BAG3-associated dilated cardiomyopathy, with meaningful comme...

Renovacor press release ( NYSE: RCOR ): Q2 GAAP EPS of -$0.23 beats by $0.41 . For further details see: Renovacor GAAP EPS of -$0.23 beats by $0.41

REN-001 IND submission planned for the second half of 2022 Data from pilot pig study showing successful cardiac transduction with REN-001 delivered via low-dose retrograde coronary sinus infusion published in Journal of the American College of Cardiology: Basic to Translat...

Research collaboration with the University of Utah's Nora Eccles Harrison Cardiovascular Research and Training Institute expands pipeline with the addition of an AAV gene therapy program for multiple genetic segments of arrhythmogenic cardiomyopathy Renovacor, Inc. (NYSE: RCOR),...

REN-001 delivered locally via low-dose retrograde coronary sinus infusion demonstrated robust, diffuse cardiomyocyte transduction in a large animal heart Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the...

Gainers: Inotiv (NOTV) +41%. TScan Therapeutics (TCRX) +23%. SomaLogic (SLGC) +19%. Veru (VERU) +18%. Celularity (CELU) +17%. Losers: Opiant Pharmaceuticals (OPNT) -16%. Renovacor (RCOR) -15%. Embecta (EMBC) -7%. Wave Life Sciences (WVE) -5%. ...

Renovacor press release (NYSE:RCOR): Q1 GAAP EPS of $0.36. Cash and cash equivalents as of March 31, 2022, totaled $70.1 million The company believes will be sufficient to fund its operating expenses and capital expenditures requirements into the second half of 2023. For further details see...